In the study, the nonsurgical spinal disc decompression treatment lowered the disk protruding size in lumbar disc escape patients. Credit: Spine MT / GlobeNewswire.

Researchers at Seoul National University Bundang Hospital, South Korea, have reported data from a study where Spine MT, a nonsurgical spinal decompression treatment device, was proven to be effective for disc treatment.

Named ‘Effect of Nonsurgical Spinal Decompression on Intensity of Pain and Herniated Disc Volume in Subacute Lumbar Herniated Disc’, the study was carried out by the hospital’s professor Pyong-bok Lee and his team.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Magnetic resonance imaging (MRI) findings showed that nonsurgical spinal disc decompression treatment could lower the size of the protruding disk in lumbar disc escape patients.

The study also demonstrated the efficacy of the device as a conservative treatment method for several spinal disc disease patients, allowing medical staff to access various treatment options for the initial ailment.

Several spinal decompression therapy devices have previously been used to treat disc patients, but no studies validated their effectiveness in aiding medical staff and patients to trust the therapy.

See Also:

Spine MT is the first device to be clinically proven for effectiveness for disc treatment across the globe.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Additionally, it was projected as a conservative treatment option for spinal disc disease patients.

Spine MT CEO In-kyu Kim said: “The characteristics of our products, developed with new domestic medical technology, are that it is possible to access treatment for each patient’s disease and it is designed to make it easy to manage treatment data for each patient. 

“In order to minimise the burden of treatment costs on patients, the legal basis has been established so that Korean medical expenses can be claimed.”

With the latest development, Kim intends to offer the Spine MT K1 and Spine MT Core spinal decompression treatment devices as a treatment method for spinal disc patients and medical staff globally.